Data Data No. of patients percentage
Gender
male 42 60%
female 28 40%
Age 49.0(18-76)
Tumor size(cm) 5.35(1-15)
Masaoka-Koga stage
I 50 71.40%
IIA 11 15.70%
IIB 1 1.40%
IIIA 3 4.30%
IIIB 3 4.30%
IV 2 2.90%
WHO type
A 8 11.40%
AB 10 14.30%
B1 12 17.10%
B2 31 44.30%
B3 9 12.90%
Myasthenia gravis
negative 37 52.90%
positive 33 47.10%
MGFA class
I 10 14.30%
IIA 4 5.70%
IIB 17 24.30%
IIIA 1 1.40%
IIIB 1 1.40%
PDL2 expression
negative 29 41.40%
positive 41 58.60%
PDL2 expression intensity
0 29 41.40%
1 16 22.90%
2 11 15.70%
3 14 20%
PDL2 expression ratio 31.9+30.1% 0-98%
PDL2 scores 70.8+102.7 0-294